Sale!

HLA T and B Cell Flow Cytometry Crossmatch Test Cost

Name: HLA T and B Cell Flow Cytometry Crossmatch Test Cost
SKU: TEST-4936
Price: 2340 AED
Availability: InStock

Original price was: 2,600 د.إ.Current price is: 2,340 د.إ.

-10%

The HLA T and B Cell Flow Cytometry Crossmatch Test is a sophisticated diagnostic procedure used to evaluate the compatibility between donor and recipient tissues prior to organ transplantation. This test is crucial in detecting the presence of antibodies in the recipient’s blood that might react against the donor’s human leukocyte antigens (HLA), which are markers found on the surface of cells. By specifically analyzing both T lymphocytes (T cells) and B lymphocytes (B cells), the test provides a comprehensive assessment of potential immune responses that could lead to transplant rejection.

Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test employs state-of-the-art flow cytometry technology. This technology allows for the precise and detailed analysis of multiple parameters of individual cells in a fluid as they pass by a laser, making it possible to detect even low levels of antibodies against donor HLA.

The cost of the HLA T and B Cell Flow Cytometry Crossmatch Test at DNA Labs UAE is 2340 AED. This price reflects the advanced technology and expertise required to perform such a detailed immune assessment, ensuring that patients receive the most accurate compatibility results before undergoing transplant procedures.

Description

HLA T and B CELL FLOW CYTOMETRY CROSSMATCH Test

Test Cost: AED 2340.0

Components:

Recipient: 2 mL (1 mL min.) serum from 1 SST and 4 mL (2 mL min.) whole blood from 1 Green Top (Sodium Heparin) tube.
Donor: 3 mL (2 mL min.) whole blood in 3 Green Top (Sodium Heparin) tubes.

Sample Condition: Ship immediately at 18-22°C. Do not freeze. Brief history in Solid Organ Transplant Consent form (Form 33) is mandatory. Doctor’s prescription on the letterhead with stamp and 1 photograph each of recipient and donor is mandatory. Above specimen requirements are for a single donor being cross-matched with a single recipient. For additional cross matches, send additional specimens of donors. Request as additional tests. Collect specimen preferably 48 hours after dialysis.

Report Delivery: 10-12 days

Method: Flow cytometry

Test Type: Transplantation

Doctor: Nephrologist

Test Department: FLOW CYTOMETRY

Pre Test Information: Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letterhead with stamp and 1 photograph each of recipient and donor is mandatory. Brief history in Solid Organ Transplant Consent form (Form 33) is mandatory.

Test Details:

HLA T & B cell flow cytometry crossmatch test is a laboratory test used in solid organ transplantation to determine the compatibility between the donor and recipient. The test involves analyzing the recipient’s serum (containing antibodies) and the donor’s T and B cells using flow cytometry. Flow cytometry is a technique that uses antibodies labeled with fluorescent dyes to detect specific cell surface markers.

During the test, the recipient’s serum is incubated with the donor’s T and B cells. If the recipient has antibodies that react with the donor’s cells, it indicates a positive crossmatch, suggesting a high risk of rejection if the transplant proceeds. On the other hand, a negative crossmatch indicates that there are no antibodies in the recipient’s serum that react with the donor’s cells, suggesting a lower risk of rejection.

The HLA T & B cell flow cytometry crossmatch test is more sensitive than traditional crossmatch tests, as it can detect antibodies that may not be detected by other methods. It helps transplant teams make informed decisions about donor-recipient compatibility and reduces the risk of organ rejection after transplantation.

Test Name	HLA T and B CELL FLOW CYTOMETRY CROSSMATCH Test
Components
Price	2340.0 AED
Sample Condition	RECIPIENT: 2 mL (1 mL min.) serum from 1 SST AND 4 mL (2 mL min.) whole blood from 1 Green Top (Sodium Heparin) tube. \nDONOR: 3 mL (2 mL min.) whole blood in 3 Green Top (Sodium Heparin) tubes.\nShip immediately at 18- 22 ?? C. DO NOT FREEZE. Brief history in Solid Organ Transplant Consent form (Form 33) is mandatory. \nDoctor’s prescription on the letter head with stamp AND 1 photograph each of recipient and donor is mandatory. Above specimen requirements are for a single donor being cross matched with a single receipient. For additional cross matches, send additional specimens of donors. Request as additional tests. Collect specimen preferably 48 hours after dialysis.
Report Delivery	10-12 days
Method	Flow cytometry
Test type	Transplantation
Doctor	Nephrologist
Test Department:	FLOW CYTOMETRY
Pre Test Information	Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letter head with stamp AND 1 photograph each of recipient and donor is mandatory. Brief history in Solid Organ Transplant Consent form (Form 33) is mandatory.
Test Details	HLA T & B cell flow cytometry crossmatch test is a laboratory test used in solid organ transplantation to determine the compatibility between the donor and recipient. The test involves analyzing the recipient’s serum (containing antibodies) and the donor’s T and B cells using flow cytometry. Flow cytometry is a technique that uses antibodies labeled with fluorescent dyes to detect specific cell surface markers. During the test, the recipient’s serum is incubated with the donor’s T and B cells. If the recipient has antibodies that react with the donor’s cells, it indicates a positive crossmatch, suggesting a high risk of rejection if the transplant proceeds. On the other hand, a negative crossmatch indicates that there are no antibodies in the recipient’s serum that react with the donor’s cells, suggesting a lower risk of rejection. The HLA T & B cell flow cytometry crossmatch test is more sensitive than traditional crossmatch tests, as it can detect antibodies that may not be detected by other methods. It helps transplant teams make informed decisions about donor-recipient compatibility and reduces the risk of organ rejection after transplantation.